ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

Numerous service and staffing cuts at IHS facilities nationally have been caused by a new HHS contract review process, ...

With fewer human research protection program staff in research institutions, mistakes will be made, and no one might be there ...

A federal judge in Texas removed a Biden-era finalized ruled by the Consumer Financial Protection Bureau that would have ...

A new large study from Denmark finds no evidence that aluminum salts used in vaccines are tied to a higher risk of childhood ...

As FDA kicked off the drug user fee reauthorization process, Commissioner Marty Makary said he’d like to see lower fees paid ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

“I was very encouraged by the data, particularly for asthma as I know vaccine hesitancy groups are concerned by this,” Anna ...

A well-placed biotech investor says U.S. policies are straining life sciences startups — and more disruption is coming.

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud.

Traditional animal models often fall short of predicting human outcomes. High costs and supply chain limitations (such as ...

Now, though, there are some bipartisan health care policies, from pharmacy-benefit manager reform to Medicare doctor payment ...